Study on Blood Glucose Variations in Tumor Patients Before and After Total Parenteral Nutrition

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

86 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-31

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the relationship among TPN, tumor and blood glucose.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Select the tumor patients in abdominal department after surgery with TPN. Monitor the blood glucose variation after TPN.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Surgery Nutrition Related Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

abdominal surgery TPN blood glucose

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tumor patients, TPN, surgery

This work involved prospective study of surgical patients receiving TPN during the calendar year of 2013 at Cancer Hospital.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1.tumor patients,2.use TPN after surgery

Exclusion Criteria

* without using TPN

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jincheng Yang

pharmacist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jincheng Yang, Doctor

Role: PRINCIPAL_INVESTIGATOR

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cancer Hospital, Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Pasquel FJ, Spiegelman R, McCauley M, Smiley D, Umpierrez D, Johnson R, Rhee M, Gatcliffe C, Lin E, Umpierrez E, Peng L, Umpierrez GE. Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care. 2010 Apr;33(4):739-41. doi: 10.2337/dc09-1748. Epub 2009 Dec 29.

Reference Type BACKGROUND

PMID: 20040658 (View on PubMed)

Yang JC, Dai YY, Wang LM, Xie YB, Zhou HY, Li GH. Glycemic Variation in Tumor Patients with Total Parenteral Nutrition. Chin Med J (Engl). 2015 Aug 5;128(15):2034-9. doi: 10.4103/0366-6999.161358.

Reference Type DERIVED

PMID: 26228214 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TPN-tumor

Identifier Type: -

Identifier Source: org_study_id